Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients

Seminars in Thrombosis and Hemostasis

Volumn 24, Issue 3, 1998, Pages 293-297

  Wada, Hideo ^a   Sakuragawa, Nobuo ^b   Shiku, Hiroshi ^a  

^a MIE UNIVERSITY   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

DIC; Leukemia; Pre DIC; Soluble fibrin monomer; Systemic vascular endothelial cell injuries

Indexed keywords

ANTIPLASMIN; ANTITHROMBIN; D DIMER; FIBRIN; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; HEMOSTATIC AGENT; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOMODULIN; THROMBOPLASTIN;

CELL DAMAGE; CONFERENCE PAPER; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOTHELIUM CELL; HEMOSTASIS; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTHROMBIN TIME; VASCULAR ENDOTHELIUM;

EID: 0031817365     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-995857     Document Type: Conference Paper

References (18)

1. Bick RL. Disseminated intravascular coagulation and related syndromes: A clinical review. Semin Thromb Hemostas 1998; 14:299-338
2. Müller-Berghaus G. Pathophysiologic and biochemical events in disseminated intravascular coagulation: Dysregulation of procoagulant and anticoagulant pathways. Semin Thromb Hemostas 1989;15:58-98
3. Ohno H, Kambayashi J, Chang SW, Kosaki G. FOY;[ethyl p(6-guanidino-hexanoxyloxy) benzoate]methaneslfonate as a serine protease inhibitor: II. In vivo effect on coagulofibrinolytic system in comparison with heparin or aprotinin. Thromb Res 1980;24:455-452
4. Sakuragawa N, Hasegawa H, Maki M, Nakagawa M, Nakashima M. Clinical evaluation of low-molecular weight heparin (FR-860) on disseminated intravascular coagulation (DIC): A multicentric cooperative double blind trial in comparison with heparin. Thromb Res 1993;72:475-500
5. Larcan A, Lambert H, Gerard A. Treatment of consumption coagulopathies. New York: Masson Publishing, 1987;165-181
6. Wada H, Wakita Y, Nakase T, et al, for the Mie DIC study group. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Thromb Hemostas 1995;74:848-852
7. Kobayashi N, Maegawa K, Takada M, Tanaka H, Gonmori H. Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan. Bibl Haematol 1987;49: 265-275
8. Wada H, Minamikawa K, Wakita Y, et al. Hemostatic study before onset of disseminated intravascular coagulation. Am J Hematol 1994;43:265-275
9. Rylatt DB, Blake AS, Cottis LE, et al. An immunoassay for human D-dimer using monoclonal antibodies. Thromb Res 1983; 31:767-778
10. Pelzer H, Schwarz A, Heinburger N. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemostas 1987;59: 101-106
11. Mimuro J, Koike Y, Sumi Y, Aoki N. Monoclonal antibodies to discrete regions in α2-plasmin inhibitor. Blood 1987;69:446-452
12. Wada H, Wakita Y, Nakase T, et al. Increased plasma soluble fibrin monomer levels in patients with disseminated intravascular coagulation. Am J Hematol 1996;51:255-260
13. Wada H, Minamikawa K, Wakita Y, et al. Increased vascular endothelial cell markers in patients with disseminated intravascular coagulation. Am J Hematol 1993;44:85-88
14. Wada H, Nakase T, Nakaya R, et al. Elevated plasma tissue factor antigen level in patients with disseminated intravascular coagulation. Am J Hematol 1994;45:232-236
15. Loskutoff DJ, Sawdey M, Mimuro J. Type I plasminogen activator inhibitor. In: Coller BS, ed. Progress in Hemostasis and Thrombosis. Philadelphia: Saunders; 1989;9:87-115
16. Wada H, Tomeoku M, Deguchi A, et al. Anticoagulant activity in cell homogenate of adult T cell leukemia. Thromb Haemostas 1988;59:197-201
17. Spero JA, Lewis JH, Hasiba V. Disseminated intravascular coagulation. Findings in 346 patients. Thromb Haemostas 1980; 43:28-33
18. Shimura M, Wada H, Wakita Y, et al. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation. Am J Hematol 1996;52:165-170